pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 8·1 min read
save

'Pharma, not really’: Top young AI talent shuns careers at big drugmakers

RIO DE JANEIRO — Mazdak Abulnaga should be the poster child for the type of employee pharma companies want to hire this year. Abulnaga, a 33-year-old postdoctoral fellow at MIT and Harvard Medical School, is building ...

May 8, 2026·read at Endpoints ↗

The 2026 ICLR conference in Rio de Janeiro (Andrew Dunn for Endpoints News) May 8, 2026 09:09 AM EDT PeopleAIPharma ‘Phar­ma, not re­al­ly’: Why AI’s top young tal­ent isn’t in­ter­est­ed in a ca­reer at big drug­mak­ers Andrew Dunn Senior Biopharma Correspondent RIO DE JANEIRO — Maz­dak Ab­ul­na­ga should be the poster child for the type of em­ploy­ee phar­ma com­pa­nies want to hire this year. Ab­ul­na­ga, a 33-year-old … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
102 words · retrieved May 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 31m agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 3h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 4h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 4h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 5h agoHealth tech investors are looking at bigger betsEndpoints